Twogee Biotech Secures €2.2 Million Seed Funding to Industrialize Circular Biomass Value Creation

Twogee Biotech, a Munich-based biotechnology
startup specializing in tailor-made enzyme solutions for the industrial conversion of biomass
into sustainable raw materials, has successfully closed a seed financing round of €2.16 million.
Investors include High-Tech Gründerfonds (HTGF) and Bayern Kapital, as well as strategic
partners such as AgriFoodTech Venture Alliance and Heinz Entsorgung.

Twogee Biotech enables industrial partners to economically convert previously low-value
biomass residues and by-products into sustainable second-generation (2G) raw materials
(residue-based, in contrast to first-generation (1G), food-based), with a particular focus on
sugars for bio- and synthetic biology applications. This is powered by a predictive development
platform that integrates enzyme screening, strain engineering, and fermentation with an
industrial mindset from the outset, shortening development cycles and reducing scale-up risks.

Founded in 2024 by Frank Wallrapp and Helge Jochens, each bringing more than ten years of
shared industry experience in biotechnology, and supported by the BioM MAxL Incubator, the
company is using the newly raised capital to accelerate the development and commercialization
of its technology. Initial MVPs and paid pilot projects with industrial partners have already
been completed. A licensing model that also enables local enzyme production at the customer
site reduces costs and CO₂ emissions while supporting the creation of decentralized, circular
value chains.

“Many industrial residual streams contain significant untapped commercial value,” says Frank
Wallrapp, CEO of Twogee Biotech. “We help our partners unlock this potential with minimal
integration effort and a clear economic value proposition.”
Helge Jochens, CTO and co-founder, adds: “A substantial portion of the funding will be
invested in expanding our new laboratories at the IZB with predictive bioreactor systems, as
well as strengthening our team with experienced process and scale-up experts. This ensures
that our developments can be reliably and economically transferred to our customers’
production scale.”

 

About Twogee Biotech

Twogee Biotech is a biotechnology company founded in 2024 and headquartered in Martinsried, Munich. Based on their innovative platform, the company develops customized enzyme and strain solutions for the industrial conversion of biogenic side and residual streams into sustainable second-generation raw materials. Twogee enables efficient utilization of biomass residues and supports the chemical industry in transitioning toward circular, low-CO₂ value creation—economically, scalably, and customer-focused.

 

More Information: Twogee Biotech Secures €2.2 Million Seed Funding to Industrialize Circular Biomass Value Creation

and visit twogee-biotech.com or follow Twogee Biotech on LinkedIn.